Skip to main content
. Author manuscript; available in PMC: 2020 May 5.
Published in final edited form as: ACS Appl Mater Interfaces. 2019 Nov 13;11(47):43879–43887. doi: 10.1021/acsami.9b15195

Figure 2.

Figure 2.

Renal/hepatic clearance and biodistribution of 89Zr-DFO-PSMAi-PEG-Cy5-C′ dots in healthy male mice after intravenous administration. (A) Cumulative clearance measurements of 89Zr-DFO-PSMAi-PEG-Cy5-C′ dots in urine and feces at various p.i. time points (n = 3; error bars: mean ± SD). (B) Biodistribution of 89Zr-DFO-PSMAi-PEG-Cy5-C′ dots in major organs and tissues, expressed in terms of %ID, on day 7 p.i. (n = 3; error bars: mean ± SD). The carcass activity represents the activity in the total body once the organs specified and have been removed and assayed separately.